SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC (EIN 453368209) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2011

Legal Domicile

Principal Officer

DAVID LISTER

Phone

9545945763

Tax Period

2024-01-01 to 2024-12-31

SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC, founded in 2011, is a small nonprofit in the Health Care sector that reported $321K in total revenue in fiscal year 2024. Revenue decreased 17% compared to the prior year. Expenses of $286K left a modest 11% surplus.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $320,100

Program Service Revenue $0

Investment Income $569

Other Revenue $0

TOTAL REVENUE $320,669

Expense Breakdown

Grants Paid $98,635

Salaries & Benefits $0

Fundraising Expenses $62,298

Program Expenses $120,483

Other Expenses $187,553

TOTAL EXPENSES $286,188

Year-over-Year Comparison

	2024	2023	Change
Revenue	$320,669	$388,338	-0.2%
Expenses	$286,188	$285,765	+0.0%
Net Income	$34,481	$102,573	-0.7%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DAVID LISTER	PRESIDENT	10.00	Director	$0	$0	$0
ORION SEWELL	DIRECTOR	5.00	Director	$0	$0	$0
STEVE STRUMPF	DIRECTOR	5.00	Director	$0	$0	$0
TOM SEDITA	DIRECTOR	5.00	Director	$0	$0	$0
JAY WEINSTOCK	TREASURER	5.00		$0	$0	$0
JODI STIEF	SECRETARY	5.00		$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$320,669	$286,188	$545,862	$34,481
2023	$388,338	$285,765	$511,381	$102,573
2022	$320,109	$192,474	$408,808	$127,635
2021	$268,656	$208,708	$140,587	$59,948

SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC